AB0860 the Predictors for 24 Months Efficacy of Denosumab, an ANTI-RANKL Antibody, on Osteoporosis in Patients With Rheumatoid Arthritis From Multicenter Study (TBCR-BONE)

doi 10.1136/annrheumdis-2017-eular.3938
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ Publishing Group Ltd and European League Against Rheumatism


Related search